StephanieAFishMD
Endocrinology • New York, NYDiabetes, Lipid Metabolism, Thyroid
Associate Professor, Medicine, Memorial Sloan Kettering Cancer Center
Overview of Dr. Fish
Dr. Stephanie Fish is an endocrinologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. She received her medical degree from New York University Grossman School of Medicine and has been in practice 20 years. She is one of 25 doctors at Memorial Sloan Kettering Cancer Center and one of 6 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Endocrinology. She has more than 20 publications and over 500 citings.
Office
530 East 74th Street
New York, NY 10021
Education & Training
University of Pennsylvania Health SystemFellowship, Endocrinology, Diabetes, and Metabolism, 2000 - 2002- University of Pennsylvania Health SystemResidency, Internal Medicine, 1997 - 2000
New York University School of MedicineClass of 1997
Certifications & Licensure
FL State Medical License 2021 - Present
NY State Medical License 2010 - 2026
CT State Medical License 2023 - 2025
NJ State Medical License 2020 - 2025
PA State Medical License 1998 - 2010- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- New York Magazine: Top Doctors Castle Connolly, 2014
Clinical Trials
- Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer Start of enrollment: 2021 Apr 27
Publications & Presentations
PubMed
- 27 citationsActive Surveillance of Papillary Thyroid Cancer: Frequency and Time Course of the Six Most Common Tumor Volume Kinetic Patterns.Robert Michael Tuttle, James Fagin, Gerald Minkowitz, Richard Wong, Benjamin Roman
Thyroid. 2022-11-01 - 4 citationsFrequent neck US in papillary thyroid cancer likely detects non-actionable findings.Kathleen Su-Yen Sek, Ingrid Tsang, Xuan Yong Lee, Omar H Albaqmi, Yanina Jimena Morosan Allo
Clinical Endocrinology. 2021-03-01 - 134 citationsVemurafenib Redifferentiation of BRAF Mutant, RAI-Refractory Thyroid Cancers.Lara Dunn, Eric J. Sherman, Shrujal S. Baxi, Vatche Tchekmedyian, Ravinder K. Grewal
The Journal of Clinical Endocrinology and Metabolism. 2019-05-01
Press Mentions
Greetings from the Editor of Clinical ThyroidologyMarch 6th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
